ASHM invites primary health practitioners to join this interactive course on HCV management.

This course aims to empower participants with the skills and confidence to diagnose, assess, manage, and treat hepatitis C (HCV) in primary care.

Target Audience

General practitioners, nurse practitioners, other practitioners prescribing or intending to prescribe s85 direct-acting
antiviral medication for HCV in primary care settings in Australia.

Speakers

1. Dr David Baker — General Practitioner, East Sydney Doctors, and Clinical Advisor, ASHM
2. Cherie Bennett — Nurse Practitioner and Medical Educator, ASHM
3. Esha Leyden — Peer Harm Reduction Worker, Queensland Injectors Health Network

Learning Outcomes

By the end of this session, participants will be able to:

• Identify when screening and testing for HCV is indicated
• Interpret HCV test results
• Discuss required pre-treatment assessments
• Determine which treatment, monitoring, and follow-up is required.

Endorsement & CPD

This course has been approved as an RACGP CPD activity in the 2023-2025 triennium.
Approved for 1.5 hours Educational Activities and 1 hour Reviewing Performance.

Funding

This course received funding from the Australian Government Department of Health.
This course is free to attend for professions aligned with the target audience.

Questions?

ASHM Education
M: 0431 320 429
E: education@ashm.org.au